These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 17462465

  • 1. Association between operative closure type and acute infection, local recurrence, and disease surveillance in patients undergoing breast conserving therapy for early-stage breast cancer.
    Indelicato D, Grobmyer SR, Newlin H, Morris CG, Haigh LS, Copeland EM, Mendenhall NP.
    Surgery; 2007 May; 141(5):645-53. PubMed ID: 17462465
    [Abstract] [Full Text] [Related]

  • 2. Long-term outcomes after breast conservation therapy for early stage breast cancer in a community setting.
    McCloskey SA, Botnick LE, Rose CM, Malcolm AW, Ozohan ML, Mena R, Llamas L, Tao ML.
    Breast J; 2006 May; 12(2):138-44. PubMed ID: 16509838
    [Abstract] [Full Text] [Related]

  • 3. Partial breast irradiation in breast conserving therapy by way of intersitial brachytherapy.
    Benitez PR, Chen PY, Vicini FA, Wallace M, Kestin L, Edmundson G, Gustafson G, Martinez A.
    Am J Surg; 2004 Oct; 188(4):355-64. PubMed ID: 15474426
    [Abstract] [Full Text] [Related]

  • 4. Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence.
    Olson TP, Harter J, Muñoz A, Mahvi DM, Breslin T.
    Ann Surg Oncol; 2007 Oct; 14(10):2953-60. PubMed ID: 17674109
    [Abstract] [Full Text] [Related]

  • 5. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
    Jolly S, Kestin LL, Goldstein NS, Vicini FA.
    Int J Radiat Oncol Biol Phys; 2006 Oct 01; 66(2):365-71. PubMed ID: 16965988
    [Abstract] [Full Text] [Related]

  • 6. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.
    Trombetta M, Julian T, Bhandari T, Werts ED, Miften M, Parda D.
    Brachytherapy; 2008 Oct 01; 7(1):29-36. PubMed ID: 18201940
    [Abstract] [Full Text] [Related]

  • 7. [Local recurrence and distant metastasis after breast-conserving therapy for patients with breast cancer].
    Meng J, Ning LS.
    Zhonghua Wai Ke Za Zhi; 2003 Apr 01; 41(4):278-81. PubMed ID: 12882672
    [Abstract] [Full Text] [Related]

  • 8. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
    Trombetta M, Julian TB, Werts DE, McWilliams W, Kim Y, Miften M, Parda D.
    Am J Clin Oncol; 2009 Jun 01; 32(3):314-8. PubMed ID: 19451803
    [Abstract] [Full Text] [Related]

  • 9. Local recurrences after conservative treatment of ductal carcinoma-in-situ of the breast without radiotherapy: the effect of age.
    Schouten van der Velden AP, Peeters PH, Koot VC, Hennipman A.
    Ann Surg Oncol; 2006 Jul 01; 13(7):990-8. PubMed ID: 16788762
    [Abstract] [Full Text] [Related]

  • 10. [A prospective multicenter clinical trial of breast conserving therapy for early breast cancer in China].
    Zhang BN, Shao ZM, Qiao XM, Li B, Jiang J, Yang MT, Wang S, Song ST, Zhang B, Yang HJ.
    Zhonghua Zhong Liu Za Zhi; 2005 Nov 01; 27(11):680-4. PubMed ID: 16438891
    [Abstract] [Full Text] [Related]

  • 11. Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy.
    Seynaeve C, Verhoog LC, van de Bosch LM, van Geel AN, Menke-Pluymers M, Meijers-Heijboer EJ, van den Ouweland AM, Wagner A, Creutzberg CL, Niermeijer MF, Klijn JG, Brekelmans CT.
    Eur J Cancer; 2004 May 01; 40(8):1150-8. PubMed ID: 15110878
    [Abstract] [Full Text] [Related]

  • 12. The impact of HER-2 status on local recurrence in women with stage I-II breast cancer treated with breast-conserving therapy.
    Harris EE, Hwang WT, Lee EA, Cengel KA, Feldman MD, Demichele A, Kao G, Solin LJ.
    Breast J; 2006 May 01; 12(5):431-6. PubMed ID: 16958961
    [Abstract] [Full Text] [Related]

  • 13. The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma.
    van der Sangen MJ, van de Poll-Franse LV, Roumen RM, Rutten HJ, Coebergh JW, Vreugdenhil G, Voogd AC.
    Eur J Surg Oncol; 2006 Feb 01; 32(1):34-8. PubMed ID: 16305821
    [Abstract] [Full Text] [Related]

  • 14. The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial.
    Poortmans PM, Collette L, Bartelink H, Struikmans H, Van den Bogaert WF, Fourquet A, Jager JJ, Hoogenraad W, Müller RP, Dubois JB, Bolla M, Van Der Hulst M, Wárlám-Rodenhuis CC, Pierart M, Horiot JC, EORTC Radiation Oncology and Breast Cancer Groups.
    Cancer Radiother; 2008 Nov 01; 12(6-7):565-70. PubMed ID: 18760649
    [Abstract] [Full Text] [Related]

  • 15. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast.
    Meijnen P, Oldenburg HS, Peterse JL, Bartelink H, Rutgers EJ.
    Ann Surg Oncol; 2008 Jan 01; 15(1):235-43. PubMed ID: 17987342
    [Abstract] [Full Text] [Related]

  • 16. Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy.
    Kreike B, Halfwerk H, Kristel P, Glas A, Peterse H, Bartelink H, van de Vijver MJ.
    Clin Cancer Res; 2006 Oct 01; 12(19):5705-12. PubMed ID: 17020974
    [Abstract] [Full Text] [Related]

  • 17. Early versus late local recurrences after conservative treatment of breast carcinoma: differences in primary tumor characteristics and patient outcome.
    Courdi A, Largillier R, Ferrero JM, Lallement M, Raoust I, Ettore F, Peyrottes I, Chamorey E, Balu-Maestro C, Chapellier C.
    Oncology; 2006 Oct 01; 71(5-6):361-8. PubMed ID: 17785993
    [Abstract] [Full Text] [Related]

  • 18. The safety of breast-conserving therapy in patients with breast cancer aged < or = 40 years.
    van der Leest M, Evers L, van der Sangen MJ, Poortmans PM, van de Poll-Franse LV, Vulto AJ, Nieuwenhuijzen GA, Brenninkmeijer SJ, Creemers GJ, Voogd AC.
    Cancer; 2007 May 15; 109(10):1957-64. PubMed ID: 17394192
    [Abstract] [Full Text] [Related]

  • 19. The preferred treatment for young women with breast cancer--mastectomy versus breast conservation.
    van Nes JG, van de Velde CJ.
    Breast; 2006 Dec 15; 15 Suppl 2():S3-10. PubMed ID: 17382859
    [Abstract] [Full Text] [Related]

  • 20. Minimizing local recurrence after breast conserving therapy using intraoperative shaved margins to determine pathologic tumor clearance.
    Camp ER, McAuliffe PF, Gilroy JS, Morris CG, Lind DS, Mendenhall NP, Copeland EM.
    J Am Coll Surg; 2005 Dec 15; 201(6):855-61. PubMed ID: 16310688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.